ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Reed Jobs launched oncology-focused venture firm Yosemite in 2023. The firm targets $350 million for its second fund. Yosemite builds biotech companies from academic research using philanthropy and venture capital. AI is now a huge part of Yosemite's work in drug discovery and clinical trial design.
Tap to vote and see what everyone thinks.
Summary by ByteBrief